XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
IHE's pharma-focused portfolio delivered higher returns over the past year, while XLV offers a broader healthcare focus with a much lower expense ratio.
Overview
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides broad healthcare exposure at a lower cost, while the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers a concentrated bet on U.S. drugmakers.
While both funds target health-related companies, they diverge sharply in portfolio construction, cost, and recent performance.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source
Originally published at www.fool.com.